WFIPP welcomes our new Corporate Partner Amara Therapeutics.
Amara Therapeutics is an Irish-based Digital Therapeutics company who develop app-based treatments for patients suffering from Overactive Bladder (OAB). The company is a spin out from the University of Galway in Ireland and their mission is to make clinically proven, guideline recommended, behavioural therapy available to all OAB patients in a convenient and cost-effective manner. The company’s first product is called BladderBoss (www.bladderboss.com) which is a direct-to-consumer app-based program that helps women better manage their bladder health, with a focus on reducing the impact of OAB. They are also developing a regulated medical device product that will be available on prescription in the US and EU (post regulatory approval). This more advanced product includes a clinician dashboard that will provide the prescribing clinician with valuable data insights they can use to better understand and treat their patients.